Patent · US Active

Use of L-carnitine or an alkanoyl L-carnitine, for the preparation of a dietary supplement or medicament for the treatment of corneal disease

US8349317B2 · kind B2 · utility

0Cited by

2References

13Claims

0Family size

Assignee

SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. · IT

Inventors

Franco Gaetani · Ariccia, IT
Janos Feher · Fara in Sabina, IT

Key dates

Filing date	Jun 30, 2006
Grant date	Jan 8, 2013
Priority date	—
Expiry date	Jul 31, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA23V2002/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Use of L-carnitine and/or one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of a dietary supplement or medicament for the treatment of corneal diseases is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.